<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Duffy | Blood Bank</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="The Duffy blood group system (ISBT 008) is clinically significant due to its role in transfusion reactions and HDFN, but it holds unique biological interest because its primary antigens, Fya and...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Duffy | Blood Bank">
<meta property="og:type" content="book">
<meta property="og:description" content="The Duffy blood group system (ISBT 008) is clinically significant due to its role in transfusion reactions and HDFN, but it holds unique biological interest because its primary antigens, Fya and...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Duffy | Blood Bank">
<meta name="twitter:description" content="The Duffy blood group system (ISBT 008) is clinically significant due to its role in transfusion reactions and HDFN, but it holds unique biological interest because its primary antigens, Fya and...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><link rel="icon" type="image/png" href="imgs/favicon.png">
<meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
<link rel="stylesheet" href="toc.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Blood Bank</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Blood Products</li>
<li><a class="" href="donors.html">Donors</a></li>
<li><a class="" href="qualification.html">Qualification</a></li>
<li><a class="" href="processing.html">Processing</a></li>
<li><a class="" href="adverse-reactions-1.html">Adverse Reactions</a></li>
<li><a class="" href="special-donations-1.html">Special Donations</a></li>
<li><a class="" href="processing-1.html">Processing</a></li>
<li><a class="" href="fda-aabb-requirements.html">FDA, AABB Requirements</a></li>
<li><a class="" href="testing.html">Testing</a></li>
<li><a class="" href="labeling.html">Labeling</a></li>
<li><a class="" href="storage.html">Storage</a></li>
<li><a class="" href="anticoagulantsadditives.html">Anticoagulants/Additives</a></li>
<li><a class="" href="temperature-requirements.html">Temperature Requirements</a></li>
<li><a class="" href="transportation.html">Transportation</a></li>
<li><a class="" href="stored-products.html">Stored Products</a></li>
<li><a class="" href="expiration.html">Expiration</a></li>
<li><a class="" href="blood-components.html">Blood Components</a></li>
<li><a class="" href="red-blood-cells.html">Red Blood Cells</a></li>
<li><a class="" href="cryoprecipitated-ahf.html">Cryoprecipitated AHF</a></li>
<li><a class="" href="platelets.html">Platelets</a></li>
<li><a class="" href="plasma.html">Plasma</a></li>
<li><a class="" href="granulocytes.html">Granulocytes</a></li>
<li><a class="" href="wbc-reduced-components.html">WBC-Reduced Components</a></li>
<li><a class="" href="frozendeglycerolized-rbcs.html">Frozen/Deglycerolized RBCs</a></li>
<li><a class="" href="apheresis-products.html">Apheresis Products</a></li>
<li><a class="" href="fractionation-products.html">Fractionation Products</a></li>
<li><a class="" href="whole-blood.html">Whole Blood</a></li>
<li><a class="" href="washed-rbcs.html">Washed RBCs</a></li>
<li><a class="" href="rejuvenated-rbcs.html">Rejuvenated RBCs</a></li>
<li><a class="" href="irradiated-components.html">Irradiated Components</a></li>
<li><a class="" href="hematopoietic-progenitors.html">Hematopoietic Progenitors</a></li>
<li><a class="" href="blood-component-qc.html">Blood Component QC</a></li>
<li class="book-part">Blood Group Systems</li>
<li><a class="" href="genetics.html">Genetics</a></li>
<li><a class="" href="basic.html">Basic</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="blood-group-inheritance.html">Blood Group Inheritance</a></li>
<li><a class="" href="biochemistryantigens.html">Biochemistry/Antigens</a></li>
<li><a class="" href="abo.html">ABO</a></li>
<li><a class="" href="lewis.html">Lewis</a></li>
<li><a class="" href="rh.html">Rh</a></li>
<li><a class="" href="mns.html">MNS</a></li>
<li><a class="" href="p1pkglobosidep.html">P1PK/Globoside(P)</a></li>
<li><a class="" href="ii.html">Ii</a></li>
<li><a class="" href="kell.html">Kell</a></li>
<li><a class="" href="kidd.html">Kidd</a></li>
<li><a class="active" href="duffy.html">Duffy</a></li>
<li><a class="" href="lutheran.html">Lutheran</a></li>
<li><a class="" href="other-blood-groups.html">Other Blood Groups</a></li>
<li><a class="" href="high-prevalence-antigens.html">High Prevalence Antigens</a></li>
<li><a class="" href="low-prevalence-antigens.html">Low Prevalence Antigens</a></li>
<li><a class="" href="hla.html">HLA</a></li>
<li><a class="" href="platelet-specific.html">Platelet-Specific</a></li>
<li><a class="" href="granulocyte-specific.html">Granulocyte-Specific</a></li>
<li><a class="" href="role-of-blood-groups-in-transfusion.html">Role of Blood Groups in Transfusion</a></li>
<li><a class="" href="immunogenicity.html">Immunogenicity</a></li>
<li><a class="" href="antigen-prevalence.html">Antigen Prevalence</a></li>
<li class="book-part">Immunology &amp; Physiology</li>
<li><a class="" href="immunology.html">Immunology</a></li>
<li><a class="" href="immune-response.html">Immune response</a></li>
<li><a class="" href="primary-secondary.html">Primary &amp; Secondary</a></li>
<li><a class="" href="b-t-cells-macrophages.html">B &amp; T cells, Macrophages</a></li>
<li><a class="" href="genetics-1.html">Genetics</a></li>
<li><a class="" href="immunoglobulins.html">Immunoglobulins</a></li>
<li><a class="" href="classes-subclasses.html">Classes &amp; Subclasses</a></li>
<li><a class="" href="structure.html">Structure</a></li>
<li><a class="" href="properties.html">Properties</a></li>
<li><a class="" href="ag-ab-interactions.html">Ag-Ab Interactions</a></li>
<li><a class="" href="principles.html">Principles</a></li>
<li><a class="" href="testing-1.html">Testing</a></li>
<li><a class="" href="complement.html">Complement</a></li>
<li><a class="" href="pathway-mechanisms.html">Pathway Mechanisms</a></li>
<li><a class="" href="biologic-properties.html">Biologic Properties</a></li>
<li><a class="" href="physiology-pathophysiology.html">Physiology &amp; Pathophysiology</a></li>
<li><a class="" href="blood-physiology.html">Blood Physiology</a></li>
<li><a class="" href="circulation-volume.html">Circulation &amp; Volume</a></li>
<li><a class="" href="composition-function.html">Composition &amp; Function</a></li>
<li><a class="" href="cell-survival.html">Cell Survival</a></li>
<li><a class="" href="cell-metabolism.html">Cell Metabolism</a></li>
<li><a class="" href="hemostasis-coagulation.html">Hemostasis &amp; Coagulation</a></li>
<li><a class="" href="factors-disorders.html">Factors &amp; Disorders</a></li>
<li><a class="" href="plt-functions-disorders.html">PLT Functions &amp; Disorders</a></li>
<li><a class="" href="hdfn.html">HDFN</a></li>
<li><a class="" href="pathophysiology.html">Pathophysiology</a></li>
<li><a class="" href="detection.html">Detection</a></li>
<li><a class="" href="treatment.html">Treatment</a></li>
<li><a class="" href="prevention.html">Prevention</a></li>
<li><a class="" href="cytopenias-1.html">Cytopenias</a></li>
<li><a class="" href="anemia.html">Anemia</a></li>
<li><a class="" href="thrombocytopenia.html">Thrombocytopenia</a></li>
<li><a class="" href="neutropenia.html">Neutropenia</a></li>
<li><a class="" href="transplantation-1.html">Transplantation</a></li>
<li><a class="" href="solid-organ.html">Solid Organ</a></li>
<li><a class="" href="hpc.html">HPC</a></li>
<li class="book-part">Serology &amp; Molecular</li>
<li><a class="" href="routine-tests.html">Routine Tests</a></li>
<li><a class="" href="blood-grouping.html">Blood Grouping</a></li>
<li><a class="" href="compatibility.html">Compatibility</a></li>
<li><a class="" href="antibody-detection.html">Antibody Detection</a></li>
<li><a class="" href="crossmatch.html">Crossmatch</a></li>
<li><a class="" href="ab-id-significance.html">Ab ID &amp; Significance</a></li>
<li><a class="" href="dat.html">DAT</a></li>
<li><a class="" href="reagents.html">Reagents</a></li>
<li><a class="" href="antiglobulin-sera.html">Antiglobulin Sera</a></li>
<li><a class="" href="blood-grouping-sera.html">Blood Grouping Sera</a></li>
<li><a class="" href="reagent-rbcs.html">Reagent RBCs</a></li>
<li><a class="" href="special-tests-reagents.html">Special Tests &amp; Reagents</a></li>
<li><a class="" href="enzymes.html">Enzymes</a></li>
<li><a class="" href="enhancement-media.html">Enhancement Media</a></li>
<li><a class="" href="lectins.html">Lectins</a></li>
<li><a class="" href="adsorptions.html">Adsorptions</a></li>
<li><a class="" href="elutions.html">Elutions</a></li>
<li><a class="" href="titrations-1.html">Titrations</a></li>
<li><a class="" href="cell-separations.html">Cell Separations</a></li>
<li><a class="" href="elisa.html">ELISA</a></li>
<li><a class="" href="molecular-techniques.html">Molecular Techniques</a></li>
<li><a class="" href="neutralization.html">Neutralization</a></li>
<li><a class="" href="thiol-reagents.html">Thiol Reagents</a></li>
<li><a class="" href="immunofluorescence.html">Immunofluorescence</a></li>
<li><a class="" href="solid-phase.html">Solid Phase</a></li>
<li><a class="" href="column-agglutination.html">Column Agglutination</a></li>
<li><a class="" href="chloroquine-diphosphate.html">Chloroquine Diphosphate</a></li>
<li><a class="" href="edta-glycine-acid.html">EDTA-Glycine Acid</a></li>
<li><a class="" href="quality-assurance.html">Quality Assurance</a></li>
<li><a class="" href="blood-samples.html">Blood Samples</a></li>
<li><a class="" href="reagents-1.html">Reagents</a></li>
<li><a class="" href="test-procedures.html">Test Procedures</a></li>
<li class="book-part">Transfusion Practice</li>
<li><a class="" href="indications.html">Indications</a></li>
<li><a class="" href="component-therapy.html">Component Therapy</a></li>
<li><a class="" href="adverse-effects.html">Adverse Effects</a></li>
<li><a class="" href="immunologic.html">Immunologic</a></li>
<li><a class="" href="nonimmunologic.html">Nonimmunologic</a></li>
<li><a class="" href="ttds.html">TTDs</a></li>
<li><a class="" href="apheresis-extracorporeal-circulation.html">Apheresis &amp; Extracorporeal Circulation</a></li>
<li><a class="" href="blood-administration-patient-blood-management.html">Blood Administration &amp; Patient Blood Management</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="duffy" class="section level1 unnumbered">
<h1>Duffy<a class="anchor" aria-label="anchor" href="#duffy"><i class="fas fa-link"></i></a>
</h1>
<p>The <strong>Duffy blood group system (ISBT 008)</strong> is clinically significant due to its role in transfusion reactions and HDFN, but it holds unique biological interest because its primary antigens, <strong>Fy<sup>a</sup> and Fy<sup>b</sup></strong>, reside on a protein that acts as a <strong>receptor for chemokines</strong> and, crucially, is used by the <strong><em>Plasmodium vivax</em> malaria parasite</strong> to invade red blood cells. The antigens are defined by amino acid variations on the <strong>Duffy Antigen Receptor for Chemokines (DARC)</strong> protein, encoded by the <em>DARC</em> gene. The common Fy(a-b-) phenotype, prevalent in individuals of African descent, provides strong resistance to <em>P. vivax</em> malaria and has a distinct molecular basis compared to other blood group null phenotypes</p>
<div id="genetics-the-darc-gene" class="section level2 unnumbered">
<h2>
<strong>Genetics: The <em>DARC</em> Gene</strong><a class="anchor" aria-label="anchor" href="#genetics-the-darc-gene"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>The Duffy antigens are encoded by the <strong><em>DARC</em> gene</strong> (also historically known as <em>FY</em>), located on <strong>chromosome 1</strong>
</li>
<li>The main alleles determining the Fy<sup>a</sup> and Fy<sup>b</sup> antigens are <em>FY*A</em> and <em>FY*B</em>
</li>
</ul>
</div>
<div id="biochemistry-the-darc-protein" class="section level2 unnumbered">
<h2>
<strong>Biochemistry: The DARC Protein</strong><a class="anchor" aria-label="anchor" href="#biochemistry-the-darc-protein"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Structure:</strong> The <em>DARC</em> gene codes for the <strong>Duffy Antigen Receptor for Chemokines (DARC)</strong> protein. This is a <strong>glycosylated, multi-pass transmembrane protein</strong> (passing through the RBC membrane 7 times), typical of many cell surface receptors</li>
<li>
<strong>Function:</strong> DARC has two well-established functions:
<ol style="list-style-type: decimal">
<li>
<strong>Chemokine Receptor</strong> It binds a wide variety of pro-inflammatory chemokines (small signaling proteins involved in inflammation and immune responses), particularly those of the CC and CXC families. It’s considered a “silent” or “scavenging” receptor, potentially regulating inflammation by binding excess chemokines without initiating traditional signaling cascades. It’s expressed not only on RBCs but also on endothelial cells lining blood vessels (especially post-capillary venules), Purkinje cells in the cerebellum, and other tissues</li>
<li>
<strong>Malaria Receptor</strong> It serves as the essential receptor for the merozoite stage of the malaria parasite <strong><em>Plasmodium vivax</em></strong> (and the related monkey malaria parasite <em>P. knowlesi</em>) to enter red blood cells</li>
</ol>
</li>
</ul>
</div>
<div id="the-major-duffy-antigens-fya-and-fyb" class="section level2 unnumbered">
<h2>
<strong>The Major Duffy Antigens: Fy<sup>a</sup> and Fy<sup>b</sup></strong><a class="anchor" aria-label="anchor" href="#the-major-duffy-antigens-fya-and-fyb"><i class="fas fa-link"></i></a>
</h2>
<p>These are the two main, antithetical antigens of the system:</p>
<ul>
<li>
<strong>Biochemical Difference:</strong> The difference between Fy<sup>a</sup> and Fy<sup>b</sup> arises from a <strong>single nucleotide polymorphism (SNP)</strong> in exon 2 of the <em>DARC</em> gene. This SNP results in a single <strong>amino acid substitution</strong> at position 42 on the first extracellular loop of the DARC protein:
<ul>
<li>
<strong>Fy<sup>a</sup> (FY1):</strong> Has <strong>Glycine (Gly)</strong> at position 42</li>
<li>
<strong>Fy<sup>b</sup> (FY2):</strong> Has <strong>Aspartic Acid (Asp)</strong> at position 42</li>
</ul>
</li>
<li>
<strong>Inheritance:</strong> An individual inherits one <em>DARC</em> allele from each parent, leading to three common genotypes:
<ul>
<li>
<em>FY*A/FY*A</em> → Phenotype: Fy(a+b-)</li>
<li>
<em>FY*B/FY*B</em> → Phenotype: Fy(a-b+)</li>
<li>
<em>FY*A/FY*B</em> → Phenotype: Fy(a+b+)</li>
</ul>
</li>
<li>
<strong>Prevalence:</strong> Antigen frequencies vary significantly among ethnic populations:
<ul>
<li>Caucasians: ~66% Fy(a+), ~83% Fy(b+)</li>
<li>Black individuals: ~10% Fy(a+), ~23% Fy(b+) (High prevalence of Fy(a-b-))</li>
<li>Asians: &gt;99% Fy(a+), ~18% Fy(b+)</li>
</ul>
</li>
</ul>
</div>
<div id="the-null-phenotype-fya-b-" class="section level2 unnumbered">
<h2>
<strong>The Null Phenotype: Fy(a-b-)</strong><a class="anchor" aria-label="anchor" href="#the-null-phenotype-fya-b-"><i class="fas fa-link"></i></a>
</h2>
<p>This phenotype, where red cells lack both Fy<sup>a</sup> and Fy<sup>b</sup>, is particularly important and has a fascinating molecular basis, especially in African populations:</p>
<ul>
<li>
<strong>Common Mechanism (African Ancestry)</strong>
<ul>
<li>
<strong>Genetics:</strong> Most Fy(a-b-) individuals of African descent possess the <em>FY*B</em> allele but have an additional <strong>SNP in the promoter region</strong> of the <em>DARC</em> gene, specifically at position -33 (T&gt;C). This mutation occurs within a binding site for the <strong>GATA-1 erythroid transcription factor</strong>
</li>
<li>
<strong>Biochemistry/Expression:</strong> The GATA-1 factor is essential for gene expression <em>in red blood cell precursors</em>. The -33C mutation disrupts GATA-1 binding, <strong>preventing transcription</strong> of the <em>DARC</em> gene <em>only in erythroid cells</em>. Therefore, DARC protein (carrying the Fy<sup>b</sup> antigen) is <strong>absent from their red blood cells</strong>
</li>
<li>
<strong>Crucially:</strong> DARC expression is <strong>NOT affected in other tissues</strong> (like endothelial cells) because gene expression there is controlled by different transcription factors. These individuals are often designated as having the <em>FY*B<sup>ES</sup></em> allele (Erythroid Silent)</li>
<li>
<strong>Malaria Resistance:</strong> This RBC-specific absence of DARC confers strong resistance to invasion by <em><em>Plasmodium vivax</em></em>
</li>
</ul>
</li>
<li>
<strong>Rare Mechanisms (Other Populations)</strong>
<ul>
<li>In other populations (e.g., Caucasians), the rare Fy(a-b-) phenotype usually results from inheriting two non-functional <em>DARC</em> alleles with mutations within the <strong>coding sequence</strong> itself (nonsense or frameshift mutations). These individuals lack DARC expression on <em>all</em> tissues, not just RBCs</li>
</ul>
</li>
</ul>
</div>
<div id="other-duffy-antigens" class="section level2 unnumbered">
<h2>
<strong>Other Duffy Antigens</strong><a class="anchor" aria-label="anchor" href="#other-duffy-antigens"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Fy3:</strong> A high-prevalence antigen present on cells expressing Fy<sup>a</sup> or Fy<sup>b</sup>. It is likely located on a different part of the DARC protein than the Fy<sup>a</sup>/Fy<sup>b</sup> site. Fy3 is <strong>absent</strong> on RBCs from individuals with the rare Fy(a-b-) phenotype caused by mutations in the coding region. However, Fy3 antigen <em>is</em> present (though perhaps weakly) on the RBCs of individuals with the common GATA-box Fy(a-b-) phenotype, as some residual protein might be expressed. Anti-Fy3 is made only by the rare “true null” individuals</li>
<li>
<strong>Fy5:</strong> Another antigen whose expression seems to depend on an <strong>interaction between the DARC protein and the Rh protein complex</strong>. Fy5 is weakened or absent on Rh<sub>null</sub> cells</li>
<li>
<strong>Fy6:</strong> An epitope on the DARC protein that appears to be the actual <strong>binding site for <em>P. vivax</em> merozoites</strong>. It is conformation-dependent and sensitive to enzyme treatment</li>
</ul>
</div>
<div id="effect-of-reagents-on-duffy-antigens" class="section level2 unnumbered">
<h2>
<strong>Effect of Reagents on Duffy Antigens</strong><a class="anchor" aria-label="anchor" href="#effect-of-reagents-on-duffy-antigens"><i class="fas fa-link"></i></a>
</h2>
<p>This is a defining characteristic used in antibody identification:</p>
<ul>
<li>
<strong>Proteolytic Enzymes (Ficin, Papain, Bromelin):</strong> Duffy antigens (Fy<sup>a</sup>, Fy<sup>b</sup>, Fy6) are <strong>DESTROYED</strong> by common enzyme treatments. The enzymes cleave the DARC protein, removing the antigenic sites</li>
<li>
<strong>Sulfhydryl Reagents (DTT, 2-ME):</strong> Duffy antigens are <strong>RESISTANT</strong> to treatment with DTT or 2-ME</li>
</ul>
</div>
<div id="duffy-antibodies-anti-fya-anti-fyb-anti-fy3" class="section level2 unnumbered">
<h2>
<strong>Duffy Antibodies (Anti-Fy<sup>a</sup>, Anti-Fy<sup>b</sup>, Anti-Fy3)</strong><a class="anchor" aria-label="anchor" href="#duffy-antibodies-anti-fya-anti-fyb-anti-fy3"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Type:</strong> Usually <strong>IgG</strong> (often IgG1), reacting best at the <strong>AHG (Coombs) phase</strong>
</li>
<li>
<strong>Stimulation:</strong> Typically <strong>immune stimulated</strong> (require exposure through transfusion or pregnancy). Anti-Fy<sup>a</sup> is encountered more commonly than anti-Fy<sup>b</sup>, likely reflecting antigen prevalence and perhaps slightly higher immunogenicity</li>
<li>
<strong>Dosage:</strong> Often show <strong>dosage</strong> (react more strongly with homozygous cells)</li>
<li>
<strong>Complement Activation:</strong> Generally do not activate complement efficiently</li>
<li>
<strong>Clinical Significance:</strong> <strong>Clinically Significant!</strong>
<ul>
<li>
<strong>Hemolytic Transfusion Reactions (HTRs):</strong> Can cause both acute and delayed HTRs, typically extravascular</li>
<li>
<strong>Hemolytic Disease of the Fetus and Newborn (HDFN):</strong> A well-recognized cause of HDFN, which can range from mild to severe</li>
</ul>
</li>
<li>
<strong>Anti-Fy3:</strong> Rare antibody made by individuals with the “true” Fy(a-b-) null phenotype (coding region mutations). Reacts with almost all cells except those lacking DARC protein. Clinically significant</li>
</ul>
</div>
<div id="key-terms-38" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-38"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong><em>DARC</em> Gene:</strong> Gene on chromosome 1 encoding the Duffy protein</li>
<li>
<strong>DARC Protein:</strong> Duffy Antigen Receptor for Chemokines; the protein carrying Duffy antigens</li>
<li>
<strong>Chemokine:</strong> Small signaling proteins involved in inflammation and immune cell trafficking</li>
<li>
<strong>Fy<sup>a</sup>/Fy<sup>b</sup>:</strong> Antithetical antigens differing by Gly/Asp at position 42</li>
<li>
<strong>Fy(a-b-):</strong> Null phenotype lacking Fy<sup>a</sup> and Fy<sup>b</sup> on RBCs</li>
<li>
<strong>GATA-1:</strong> Erythroid transcription factor essential for gene expression in RBC precursors</li>
<li>
<strong>Promoter Mutation:</strong> Genetic change in the regulatory region upstream of a gene (e.g., the -33 T&gt;C mutation in <em>DARC</em> causing the common Fy(a-b-) phenotype)</li>
<li>
<strong><em>Plasmodium vivax</em>:</strong> Malaria parasite that uses DARC to invade red blood cells</li>
<li>
<strong>Enzyme Treatment:</strong> Use of proteolytic enzymes (ficin, papain) which destroy Duffy antigens</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  sections = [];
  topics = [];
  function hide_label() {
    // sections
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          elem.classList
          .contains('book-part')
          ? sections.push(elem)
          : '';
      });

    // topics
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? topics.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    // sections
    count_sections = 0;
    prev_sections_elem = '';
    sections
      .forEach((elem) => {
      if(count_sections === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count_sections = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_sections_elem.classList.add('hide_label');
        } else {
          prev_sections_elem.classList.remove('hide_label');
        }
      }
      prev_sections_elem = elem;
    });
    // topics
    count_topics = 0;
    prev_topic_elem = '';
    topics
      .forEach((elem) => {
      if(count_topics === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count_topics = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_topic_elem.classList.add('hide_label');
        } else {
          prev_topic_elem.classList.remove('hide_label');
        }
      }
      prev_topic_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="kidd.html">Kidd</a></div>
<div class="next"><a href="lutheran.html">Lutheran</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#duffy">Duffy</a></li>
<li><a class="nav-link" href="#genetics-the-darc-gene">Genetics: The DARC Gene</a></li>
<li><a class="nav-link" href="#biochemistry-the-darc-protein">Biochemistry: The DARC Protein</a></li>
<li><a class="nav-link" href="#the-major-duffy-antigens-fya-and-fyb">The Major Duffy Antigens: Fya and Fyb</a></li>
<li><a class="nav-link" href="#the-null-phenotype-fya-b-">The Null Phenotype: Fy(a-b-)</a></li>
<li><a class="nav-link" href="#other-duffy-antigens">Other Duffy Antigens</a></li>
<li><a class="nav-link" href="#effect-of-reagents-on-duffy-antigens">Effect of Reagents on Duffy Antigens</a></li>
<li><a class="nav-link" href="#duffy-antibodies-anti-fya-anti-fyb-anti-fy3">Duffy Antibodies (Anti-Fya, Anti-Fyb, Anti-Fy3)</a></li>
<li><a class="nav-link" href="#key-terms-38">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/blob/main/Rmd/02-B-09.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/edit/main/Rmd/02-B-09.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-04-08 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
